Heterogeneity in Efficacy and Safety Endpoints for Pediatric Clinical Trials in Inflammatory Bowel Disease: A Need for Harmonization

Posted on July 15, 2022 by Gastroenterology Journal
This entry was posted in News. Bookmark the permalink.